Vimarsana
Biggest News Aggregation in the World

Randallj Bateman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randallj Bateman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randallj Bateman Today - Breaking & Trending Today

Alzheimer's blood test performs as well as FDA-approved spinal fluid tests - Vimarsana News

Alzheimer's blood test performs as well as FDA-approved spinal fluid tests

Scientists report a major step toward a simple blood test for Alzheimer’s disease. Researchers at Washington University School of Medicine in St. Louis and Lu

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods - Vimarsana News

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

A simple blood test to diagnose Alzheimer's disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.

Alzheimer's blood test performs as well as FDA-approved spinal fluid tests - The Source - Vimarsana News

Alzheimer's blood test performs as well as FDA-approved spinal fluid tests - The Source

Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden showed that a blood test is as good at identifying people in early stages of the disease as cerebrospinal fluid tests approved by the Food and Drug Administration for Alzheimer’s diagnosis.

Source: wustl.edu
Alzheimer's blood test could replace spinal taps and brain scans - Vimarsana News

Alzheimer's blood test could replace spinal taps and brain scans

A simple blood test to diagnose Alzheimer's disease could make early diagnosis and treatment accessible to more people.

Antiamyloid Gantenerumab Disappoints in Phase 3 Trials - Vimarsana News

Antiamyloid Gantenerumab Disappoints in Phase 3 Trials

The antiamyloid monoclonal antibody gantenerumab led to a lower amyloid plaque burden but no clear cognitive benefit in early Alzheimer's disease in twin pivotal trials.